| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/JAMA.1970.03180010023004 |
| P698 | PubMed publication ID | 5469062 |
| P2093 | author name string | W S Harris | |
| G J Taylor | |||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 81-85 | |
| P577 | publication date | 1970-10-01 | |
| P1433 | published in | The Journal of the American Medical Association | Q1470970 |
| P1476 | title | Cardiac toxicity of aerosol propellants | |
| P478 | volume | 214 |
| Q66695941 | "Sudden sniffing death" after inhalation of domestic lipid-aerosol |
| Q40168042 | A perspective on particulate size analysis of consumer aerosol products |
| Q69859037 | Adverse effects and complications of treatment with beta-adrenergic agonist drugs. Committee on drugs, the American Academy of Allergy and Immunology |
| Q43948041 | An Electrocardiographic Pattern of Acute Myocardial Infarction Associated with Excessive Use of Aerosolized Isoproterenol |
| Q35939024 | Blood fluorocarbon levels following exposure to household aerosols |
| Q23922446 | Cardiovascular disease and environmental exposure |
| Q71072228 | Cardiovascular effects of potential occupational hazards |
| Q54667413 | Comparison of Isoproterenol and Isoproterenol-Phenylephrine Aerosols |
| Q35927248 | Deliberate inhalation of volatile hydrocarbons: a review |
| Q70471148 | Determination of Fluorinated Hydrocarbon Propellants in Blood of Dogs after Aerosol Administration |
| Q41408945 | Effects of fluorocarbon propellants on respiratory flow and ECG. |
| Q48350819 | Electroencephalographic and autonomic responses to trichloroethylene inhalation in freely moving rats |
| Q66934134 | Fatal arrhythmia following deodorant inhalation |
| Q66695940 | Fibrinolysis and tourniquet |
| Q52719637 | Five Fluorocarbons for Administration of Aerosol Bronchodilators |
| Q35601045 | Further observations on the cardiotoxicity of isoprenaline during hypoxia |
| Q34069251 | Myocardial infarction and primary ventricular fibrillation after glue sniffing. |
| Q39920393 | Old and New Issues in the Safety Evaluation of Cosmetics and Toiletries |
| Q33618415 | Persistent visual hallucinations secondary to chronic solvent encephalopathy: case report and review of the literature |
| Q39511528 | Pharmaceutical excipients. Adverse effects associated with 'inactive' ingredients in drug products (Part II). |
| Q35132664 | Physiological response to aerosol propellants |
| Q34069226 | Solvent abuse and the heart |
| Q71249841 | Sudden death from toluene abuse |
| Q70689227 | The ambient air, the good of it and the bad of it: the development of therapeutic gases and air pollution |
| Q39481325 | The beta 2-agonist controversy. Observations, explanations and relationship to asthma epidemiology |
| Q44853146 | The electrical sequelae of aerosol inhalation |
| Q70533546 | The incidence and correlates of marihuana use in an Australian undergraduate population |
| Q68305820 | The use of epinephrine in the treatment of older adult asthmatics |
| Q39665520 | The young Damocles. The adolescent at high risk for serious or fatal status asthmaticus |
| Q34063205 | Ventricular arrhythmias induced in monkeys by the inhalation of aerosol propellants |
| Q34014635 | β-Adrenergic Bronchodilators |
Search more.